Join the Economic Mission at WATEC Israel 2013...
Intel Israel's five locations, some with multiple facilities, include design and development centers, fabs, and sales and marketing support offices. Israel itself is home to 6.7 million residents. It comprises a mosaic of people with varied ethnic backgrounds, lifestyles, religions, cultures and traditions, all thousands of years in the making. In collaboration with local leadership, Intel Israel contributes to education, employment and the development of suppliers and infrastructure.
Intel Israel's employees take active roles in community activities, though Intel also contributes other resources and equipment to science education, advanced mathematical skills, entrepreneurship and the development of products, production and marketing throughout the country. Intel strongly supports science and technology education through Intel® Innovation in Education and the Intel Visitors Center, where students and community members can peek into the high-tech world of Intel.
Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Petah Tikva, Israel. It specializes in generic and proprietary pharmaceuticals and active pharmaceutical ingredients. It is the largest generic drug manufacturer in the world  and one of the 20 largest pharmaceutical companies worldwide. In 2008, its sales totaled $11.08 billion, of which a major portion was in Europe and North America. After its acquisition of U.S. rival Ivax Corporation in January 2006, the company has about 28,000 employees in 50 countries. Teva's facilities are located in Israel, North America, Europe, and Latin America. As of February 2009[update], Teva is the tenth largest company by market capitalization on the Nasdaq just behind Gilead Sciences, and is a member of both the NASDAQ-100 and TA-25 Index (in which it represents 9.5% of the total Index value).